Roivant Sciences
ROIV
ROIV
181 hedge funds and large institutions have $5.02B invested in Roivant Sciences in 2023 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 58 increasing their positions, 46 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+34
Holders Change %
+23.13%
% of All Funds
2.85%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
58
Increased
58
Reduced
46
Closed
23
Calls
$8.47M
Puts
$1.45M
Net Calls
+$7.02M
Net Calls Change
+$3.44M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$131M |
| 2 |
BlackRock
New York
|
$125M |
| 3 |
PSC
Patient Square Capital
Menlo Park,
California
|
$127M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
$58.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
$363M |
